Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

Cost of arthropathic diseases therapy with biologicals disease modifying drugs (bDMARs): a 5-year cost analysis at national level

AbstractThis study analysed the changes in the reimbursed cost, prices and utilization of biological medicines for a 5-year time horizon, encompassing three major arthropathic diagnoses, rheumatoid arthritis (RA), psoriatic arthropathies (PsA) and ankylosing spondylitis (AS), from the point of view...

Full description

Bibliographic Details
Main Authors: Konstantin Tachkov, Vladimira Boyadzhieva, Ivan Manev, Nikolay Stoilov, Zornitsa Mitkova, Konstantin Mitov, Guenka Petrova
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Biological medicines
arthropathic diseases
cost of therapy
diseases modifying antirheumatic medicines
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2022.2131468

Internet

https://www.tandfonline.com/doi/10.1080/13102818.2022.2131468

Similar Items